10/8/2008 10:55:57 AM
LOS ANGELES--(BUSINESS WIRE)--Moraga Biotechnology Corporation, an adult stem cell company based in Los Angeles, California, announces the licensing of its blood-derived Blastomere-Like Stem Cells (BLSCs) with Pharmacells, Ltd. headquartered in Glasgow, Scotland. The licensing agreement provides Pharmacells access to Moraga’s proprietary adult stem cell technology for banking its BLSCs that have been isolated, processed, and cryopreserved from the blood of individuals. Moraga’s scientists have found that its BLSCS are able to differentiate into most tissues and organs of the body.
comments powered by